News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories' Synthetic Vaccine to Fight Growing Meningitis

Date: 26/10/2015

Hilleman Laboratories' Synthetic Vaccine to Fight Growing Meningitis

New Delhi, 26 October 2015: Global vaccine research and development organization, Hilleman Laboratories, has announced the publication of an original scientific report in the Royal Society of Chemistry Advances Journal based on the synthesis of a meningitis vaccine for Neisseria meningitidis sero group X (MenX).

View All